Can-Fite BioPharma (CANF) Reports Q1 Loss of NIS0.21/Share

Can-Fite BioPharma (NYSE: CANF) reported Q1 EPS of (NIS0.21), versus (NIS0.06) reported last year. Revenue for the quarter came in at NIS214 thousand, versus NIS0 reported last year.

For earnings history and earnings-related data on Can-Fite BioPharma (CANF) click here.

You May Also Be Interested In

• Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
• Bernstein SocGen Group Reiterates Outperform Rating on Centene (CNC), discusses CFO change
• Bernstein on U.S. telecom: "Another strong quarter"